ADBiotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '24 Oct 10, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	31,717	29,935	30,712	45,092	37,494
Market Cap Growth	-27.86%	-2.53%	-31.89%	20.26%	-
Enterprise Value	37,954	39,459	35,183	49,488	-
Last Close Price	3470.00	3275.00	3360.00	9100.00	7566.67
PE Ratio	-	-10.45	28.35	-26.22	-5.15
PS Ratio	3.22	2.86	2.89	3.81	3.82
PB Ratio	5.63	2.38	1.90	8.83	4.02
P/FCF Ratio	58.36	398.99	-3.30	-7.85	-5.94
P/OCF Ratio	39.50	95.05	-3.57	-20.63	-36.78
EV/Sales Ratio	3.86	3.77	3.31	4.18	-
EV/EBITDA Ratio	-10.08	-10.84	-8.26	-54.80	-
EV/EBIT Ratio	-7.47	-8.27	-7.06	-31.83	-
EV/FCF Ratio	69.83	525.92	-3.78	-8.61	-
Debt / Equity Ratio	2.44	1.08	0.79	2.58	0.78
Debt / FCF Ratio	19.82	181.40	-1.37	-2.29	-1.15
Asset Turnover	0.36	0.35	0.41	0.59	-
Inventory Turnover	2.46	2.79	2.97	3.52	-
Quick Ratio	0.36	0.98	0.89	0.50	0.90
Current Ratio	0.58	1.19	1.20	0.69	1.32
Return on Equity (ROE)	-114.50%	-37.78%	25.33%	-36.92%	-
Return on Assets (ROA)	-10.33%	-10.09%	-11.98%	-4.88%	-
Return on Capital (ROIC)	-12.68%	-10.82%	-13.19%	-5.58%	-
Earnings Yield	-26.35%	-9.57%	8.78%	-5.91%	-19.59%
FCF Yield	1.71%	0.25%	-30.34%	-12.74%	-16.83%
Buyback Yield / Dilution	10.35%	9.33%	-31.17%	-53.77%	-
Total Shareholder Return	10.35%	9.33%	-31.17%	-53.77%	-

Source: S&P Capital IQ. Standard template. Financial Sources.